News
Article
Author(s):
Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved patient outcomes.
(Image credit: ©RealityImages/AdobeStock)
Alcon announced presentations during the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone booth.1 APACRS is being held August 21-23, 2025, at the Mahatma Mandir Convention and Exhibition Centre in Ahmedabad, India.
“APACRS brings together leading experts and their insights from across the region, creating an ideal environment to engage in critical topics such as the evolving needs of cataract care in the aging population,” Massimo Cerrone, Vice President, Surgical for Alcon Asia Pacific, said in a press release.1
“Through a dynamic agenda, surgeons can explore Alcon’s latest innovations and their value through clinical evidence, real-world insights, and peer experience across Asia-Pacific.”
The company will be presenting an e-poster on the prospective study, “To Evaluate the Visual Outcomes and Patient Satisfaction After Bilateral Vivity IOL Implantation in Patients with Mild Irregular Astigmatism.” This study, conducted by Ashvin Agarwal, MD, is one of more than 10 clinical studies supporting Alcon’s Vivity. Vivity is an extended depth of focus (EDOF) intraocular lens (IOL) studied in special populations with various comorbidities. Analyses of Vivity show patient satisfaction across the more than 700 patients.
Shail Vasavada, DO, DNB, FICO, will be presenting a prospective, randomized, single-masked, single-center study titled, “Retinal Perfusion During Cataract Surgery with Varying Intraocular Pressure in Comorbid Eyes.” The data from the study underlines the benefits of performing cataract surgery at more physiologic IOP in patients with diabetic retinopathy (DR).1
In addition to the presentations, Alcon will host four symposia.1
“We are excited that India is hosting APACRS for the second time. The event is an ideal platform to showcase our breakthrough technologies like the Advanced Technology IOL portfolio and UNITY VCS/CS, and foster meaningful exchange amongst ECPs,” Amar Vyas, Country Head, Alcon India, said in a press release.1
“As cataract procedures rise, it’s critical that advanced technologies are both clinically proven across diverse patient populations and accessible to those who need them. We remain committed to empowering surgeons with science-backed solutions that elevate surgical precision and patient outcomes.”
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.